Research use only · third-party COA for every lot support@retatrutide-peptide.info
Retatrutide-Peptide.info

Store

Order retatrutideBasketLab reportsWholesale

Start here

About retatrutideBenefitsResultsReviewsFDA status

Protocols

Dosage chartCalculatorReconstitutionInjectionHalf-lifeStacks

Safety

Side effectsFor womenBlood sugarMuscle

Compare

vs Tirzepatidevs Semaglutidevs other GLP-1s

Buying

Where to buyPriceCompoundedVendorsOral form

Company

About usReview boardContent standardsSourcesHelp
Author

Nir Barzilai, MD

Holds the role of Professor in both Medicine and Genetics at Albert Einstein College of Medicine, where he also serves as the founding director of the Institute for Aging Research.

Nir Barzilai, MD

Author

He serves as Professor of Medicine and Genetics at the Albert Einstein College of Medicine, where he also founded and directs the Institute for Aging Research. The TAME metformin trial was his brainchild.

Education and training

StageInstitution
MDIn 1985, he earned his degree from the Technion, Israel Institute of Technology.
ResidencyYale University
Fellowship, MetabolismYale University
He completed a fellowship in Endocrinology and Molecular Medicine.Cornell

Current positions

  • At Albert Einstein College of Medicine, he holds professorships in both the Department of Medicine (Endocrinology) and the Department of Genetics.
  • He is the holder of the Ingeborg and Ira Leon Rennert Chair in Aging Research.
  • As Founding Director of the Institute for Aging Research, he also oversees what is known as the Institute for Geroscience.
  • He serves as leader of the Nathan Shock Center of Excellence in the Basic Biology of Aging.
  • He directs the Paul F. Glenn Center for the Biology of Human Aging Research.
  • Director, Longevity Genes Project
  • He was selected to be President of the Global Academy for Health & Lifespan Research.

Research areas

His research interests encompass geroscience, the genetics behind exceptional longevity, metformin as an anti-aging intervention, how nutrition and genetics influence lifespan, the GH/IGF-1 axis, and metabolism in mammalian aging.

Key discoveries

Encompassing over 600 centenarian families, the Longevity Genes Project has uncovered gene variants (CETP, APOC3, ADIPOQ, TSHR, IGF1R) linked to exceptional longevity and a lower risk of cardiovascular disease, cancer, type 2 diabetes, and dementia.

TAME trial

He conceived and developed the TAME (Targeting Aging with Metformin) multicenter trial, which investigates whether metformin can delay the onset of multiple age-related conditions at once. The trial's strategic aim is to convince the FDA to recognize aging itself as a treatable condition.

Book

He wrote the book 'Age Later: Health Span, Life Span, and the New Science of Longevity'. (2020, St. Martin's Press)

Awards

His accolades include the Irving S. Wright Award of Distinction in Aging Research (2010), the IPSEN Longevity Award, the NIA Nathan Shock Award, the Beeson Award, the Paul Glenn Foundation Award, and the Senior Ellison Foundation Award. He is also a Fellow of the Association of American Physicians and the New York Academy of Medicine.

Profiles and links

Retatrutide vial
Retatrutide
Research-grade · COA per lot
$125.00

Retatrutide vial
Retatrutide98%+ purity · third-party tested
$125.00